Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medifast Inc (MED)

Medifast Inc (MED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 198,634
  • Shares Outstanding, K 10,938
  • Annual Sales, $ 1,072 M
  • Annual Income, $ 99,410 K
  • EBIT $ 11 M
  • EBITDA $ 24 M
  • 60-Month Beta 1.13
  • Price/Sales 0.18
  • Price/Cash Flow 1.62
  • Price/Book 0.93

Options Overview Details

View History
  • Implied Volatility 40.63% ( -8.04%)
  • Historical Volatility 45.16%
  • IV Percentile 9%
  • IV Rank 5.63%
  • IV High 127.77% on 07/18/24
  • IV Low 35.43% on 11/24/23
  • Put/Call Vol Ratio 0.70
  • Today's Volume 207
  • Volume Avg (30-Day) 524
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 9,132
  • Open Int (30-Day) 11,906

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.03
  • Number of Estimates 2
  • High Estimate 0.16
  • Low Estimate -0.10
  • Prior Year 1.09
  • Growth Rate Est. (year over year) -97.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.07 +6.39%
on 11/19/24
21.08 -13.85%
on 11/05/24
+0.05 (+0.28%)
since 10/18/24
3-Month
17.07 +6.39%
on 10/15/24
21.08 -13.85%
on 11/05/24
-1.26 (-6.49%)
since 08/20/24
52-Week
17.07 +6.39%
on 10/15/24
76.42 -76.24%
on 12/12/23
-49.34 (-73.10%)
since 11/20/23

Most Recent Stories

More News
Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

OLPX : 1.8200 (+4.00%)
NATR : 16.00 (+0.19%)
EL : 65.33 (+0.83%)
MED : 18.16 (+4.85%)
ELF : 119.00 (-2.23%)
Nature's Sunshine (NATR) Q3 Earnings Report Preview: What To Look For

Nature's Sunshine (NATR) Q3 Earnings Report Preview: What To Look For

HLF : 8.41 (+8.94%)
NATR : 16.00 (+0.19%)
MED : 18.16 (+4.85%)
Nu Skin Earnings: What To Look For From NUS

Nu Skin Earnings: What To Look For From NUS

HLF : 8.41 (+8.94%)
NUS : 7.49 (-1.32%)
MED : 18.16 (+4.85%)
Edgewell Personal Care (EPC) Q3 Earnings: What To Expect

Edgewell Personal Care (EPC) Q3 Earnings: What To Expect

HLF : 8.41 (+8.94%)
EPC : 34.69 (unch)
MED : 18.16 (+4.85%)
Olaplex (OLPX) To Report Earnings Tomorrow: Here Is What To Expect

Olaplex (OLPX) To Report Earnings Tomorrow: Here Is What To Expect

OLPX : 1.8200 (+4.00%)
HLF : 8.41 (+8.94%)
MED : 18.16 (+4.85%)
MED Q3 Earnings Beat, Revenues Fall on Customer Acquisition Challenges

Medifast, Inc. MED reported third-quarter 2024 results, with the bottom and top lines surpassing the Zacks Consensus Estimate. However, both metrics declined year over year. Results were hurt by challenging...

FRPT : 153.00 (-2.16%)
VITL : 30.13 (unch)
UNFI : 22.84 (+4.58%)
MED : 18.16 (+4.85%)
Medifast: Q3 Earnings Snapshot

Medifast: Q3 Earnings Snapshot

MED : 18.16 (+4.85%)
Medifast (NYSE:MED) Posts Better-Than-Expected Sales In Q3 But Quarterly Guidance Underwhelms

Medifast (NYSE:MED) Posts Better-Than-Expected Sales In Q3 But Quarterly Guidance Underwhelms

MED : 18.16 (+4.85%)
Medifast (MED) To Report Earnings Tomorrow: Here Is What To Expect

Medifast (MED) To Report Earnings Tomorrow: Here Is What To Expect

HLF : 8.41 (+8.94%)
EL : 65.33 (+0.83%)
MED : 18.16 (+4.85%)
Health and Wellness Sector Sees New Opportunities in Weight Loss Drug Market

Issued on behalf of PlantX Life Inc. VANCOUVER – USA News Group News Commentary – With over 100 million Americans facing obesity and rates rising globally, it’s no surprise that analysts...

WW : 0.9500 (+7.95%)
HLF : 8.41 (+8.94%)
MS : 131.69 (-0.42%)
MED : 18.16 (+4.85%)
VEGA.CN : 0.3550 (-5.33%)
PLTXF : 0.2500 (+1.63%)
AMGN : 287.87 (+2.83%)

Business Summary

Medifast is a leading manufacturer and distributor of clinically-proven healthy living products and programs. The company produces, distributes and sells weight loss, weight management and healthy living products throughits direct online channels as well as franchise weight control centers. The company...

See More

Key Turning Points

3rd Resistance Point 19.57
2nd Resistance Point 18.89
1st Resistance Point 18.53
Last Price 18.16
1st Support Level 17.49
2nd Support Level 16.81
3rd Support Level 16.45

See More

52-Week High 76.42
Fibonacci 61.8% 53.75
Fibonacci 50% 46.74
Fibonacci 38.2% 39.74
Last Price 18.16
52-Week Low 17.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar